| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Accounting Officer
1 company
William Lawrence Phelan last filed a Form 4 in May 2023, as Chief Accounting Officer at MDXG. William Lawrence Phelan's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, William Lawrence Phelan's trades have earned a below-average insider score of 29/100 across 7 rated trades. Over a 12-month horizon, 14.3% of those trades were profitable, with an average 12-month return of -60.2%.
At the last filing, the largest reported position was 184,219 shares of MDXG. The MDXG filings lean toward selling, a net 22,469 shares.
William Lawrence Phelan has 14 Form 4 filings on record from July 2020 to May 2023, all as Chief Accounting Officer at Mimedx Group (MDXG), 2020–2023.
The 14 reported transactions were 7 open-market sales, 6 stock awards and 1 tax withholding.
Counted by filing, the open-market trades come to no purchases and 7 sales worth about $93K.
The largest open-market sale was 5,750 shares of MDXG at an average $3.81 on May 6, 2022, about $22K. Twelve months later MDXG was up 59%.
None of the 4 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
Shares as reported in the last Form 4 for each company; the most recent is from May 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 10, 2023 | MDXG Mimedx Group, Inc. | Chief Accounting Officer | Sell | 1,595 | $5.93 | $9,452.13 | -0.9% | +21.0% | +19.5% | |
| May 2, 2023 | MDXG Mimedx Group, Inc. | Chief Accounting Officer | Sell | 5,200 | $3.80 | $19,739.20 | -2.7% | +111.8% | +91.9% | |
| Apr 25, 2023 | MDXG Mimedx Group, Inc. | Chief Accounting Officer | Sell | 1,628 | $3.74 | $6,095.23 | -0.8% | +103.8% | +75.7% | |
| Apr 11, 2023 | MDXG Mimedx Group, Inc. | Chief Accounting Officer | Sell | 1,632 | $3.31 | $5,401.92 | -0.8% | +100.3% | +98.5% | |
| Mar 7, 2023 | MDXG Mimedx Group, Inc. | Chief Accounting Officer | Sell | 3,396 | $4.24 | $14,414.66 | -2.3% | +38.6% | +92.1% | |
| May 6, 2022 | MDXG Mimedx Group, Inc. | Chief Accounting Officer | Sell | 5,750 | $3.81 | $21,907.50 | -3.8% | +5.3% | +59.4% | |
| Mar 8, 2022 | MDXG Mimedx Group, Inc. | Chief Accounting Officer | Sell | 3,268 | $4.86 | $15,879.21 | -3.2% | -19.7% | -15.5% |